Mirapex Plaintiffs Haggle Over Bellwether Details

Law360, New York (August 14, 2007, 12:00 AM EDT) -- As Pfizer Inc. prepares to face off in court over allegations that its drug Mirapex causes a sudden, compulsive urge to gamble in patients with restless legs syndrome, the pharmaceutical giant continues to wrangle with plaintiffs' attorneys over the proper sequencing for the bellwether trial process.

On Monday, attorneys at Robins, Kaplans, Miller & Ciresi LLP filed a motion asking the U.S. District Court for the District of Minnesota to sign off on its plan for how the bellwether trials should unfold in the multidistrict litigation...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.